About

Dr. Luca Cindolo is a leading urologic surgeon whose research has significantly advanced minimally invasive surgery for kidney and prostate conditions. His work centers on refining robotic and laparoendoscopic techniques to improve patient outcomes. He is best known for his pivotal role in the CLOCK randomized controlled trial, which rigorously compared on-clamp versus off-clamp robot-assisted partial nephrectomy (RAPN). This landmark study, cited over 100 times, provided critical evidence on functional and safety outcomes, helping surgeons optimize renal function preservation during tumor removal. Dr. Cindolo also spearheaded the largest multi-institutional analysis of laparoendoscopic single-site surgery (LESS) in urology, a study of over 1,000 cases with 277 citations, which established risk factors for complications and conversion. His contributions extend to benign prostatic hyperplasia, where his systematic reviews and meta-analyses of over 6,500 cases have helped define the standard surgical approach for large prostates. With a consistent focus on high-level evidence, Dr. Cindolo’s research has shaped modern urologic practice, offering clear, data-driven guidance for complex surgical decisions.

Research Focus

Key Achievements

14
H-Index
25
Papers
902
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Laparoendoscopic Single-site Surgery in Urology: Worldwide Multi-institutional Analysis of 1076 Cases
277 citations · 2011
📈 Most Prolific Year: 2022 (4 Papers)
🤝 Key Collaborators: 202
🏛 Institutions: University of Chieti-Pescara, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Agenzia Sanitaria Regionale Abruzzo, Ospedale San Donato, Clinica Valle Giulia, Villa Torri Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago